Joost Postmes

Joost Postmes is an experienced executive with a strong background in the healthcare and media sectors. Currently serving as CEO of Triticum Exploitatie BV since March 2003, Joost oversees the production of L-Mesitran, an innovative wound care product line utilizing patented honey-based technologies, with a global market presence in over 56 countries. Additionally, as CEO of Sion Biotext bv since March 2020, Joost leads the manufacturing of FFP2 facemasks for hospital use. Joost has also held the position of CEO and owner of 241 Productions, where the focus was on producing content for international television broadcasters from September 1998 to March 2003, and worked as a freelance broadcaster for TV news programs between 1995 and 1998. Educational qualifications include an LLM in Law from Maastricht University and a VWO from St Maartenscollege.